Table 2 Tumour response (WHO) (Miller et al, 1981) (ITT and PP populations)
BDC study | GBC study | |||
|---|---|---|---|---|
ITT population Number (%) of evaluable patients ( n =37) | PP population Number (%) of evaluable patients ( n =34) | ITT population Number (%) of evaluable patients ( n =35) | PP population Number (%) of evaluable patients ( n =31) | |
CR | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
PR | 7 (19) | 7 (20) | 8 (23) | 8 (26) |
NC | 20 (54) | 20 (59) | 16 (46) | 16 (52) |
PD | 6 (16) | 6 (18) | 6 (17) | 6 (19) |
Not assessable | 4 (11) | 1 (3) | 5 (14) | 1 (3) |
Overall response (CR+PR) | 7 (19) | 7 (20) | 8 (23) | 8 (26) |
Disease control (CR+PR+NC) | 27 (73) | 27 (79) | 24 (69) | 24 (77) |
